Chartered Accountant for Surgeons — Cabinet Hayot Expertise

Private surgeons — whether orthopedic, visceral, cardiovascular, plastic, neurosurgeons or maxillofacial specialists — face unparalleled fiscal, social and wealth complexity among healthcare professions. Your surgical fees frequently reach €200,000 to €500,000 per year, but your effective tax burden can be reduced by 30 to 50% with an adapted structure. Cabinet Hayot Expertise is the specialist chartered accountant for private surgeons in Paris who turns your tax pressure into a wealth management lever.

A chartered accountant for surgeons supports the private practitioner across all financial and fiscal dimensions: BNC 2035 declaration, optimization of surgical equipment depreciation, VAT compliance on aesthetic procedures, management of CARMF and URSSAF contributions, advice on transitioning to SELARL or SELAS, and wealth structuring via SPFPL and SCI. They transform the tax pressure of high liberal income into a measurable wealth strategy.

High-pressure BNC fiscal regime#

Virtually all private surgeons operate under the Non-Commercial Profits (BNC) regime with an obligation to file a 2035 declaration. The micro-BNC threshold (€83,600 in 2026) is structurally exceeded by surgeons: a sector 2 orthopedic surgeon in Paris receives an average of €350,000 to €450,000 in gross fees.

Immediate tax consequence: at €300,000 net profit, a surgeon as a sole proprietor pays:

• Income tax: ~€110,000 (45% marginal bracket above €181,917)
• CARMF + URSSAF social contributions: ~€120,000 (~40% of profit)
• Net disposable income: €300,000 − €110,000 − €120,000 = €70,000 or €5,833/month

Our intervention: with an optimized SELARL + SPFPL structure, the same surgeon can retain €150,000 to €180,000 in net disposable income — 2 to 2.5 times more — while building a lasting wealth structure.

VAT and aesthetic surgery: a little-known fiscal risk#

Purely aesthetic procedures (cosmetic rhinoplasty, breast augmentation, facelifts, liposuction, cosmetic botox/hyaluronic acid injections) are subject to 20% VAT in France. Therapeutic or reconstructive procedures (post-cancer surgery, congenital malformations, trauma sequelae) remain VAT-exempt.

Our aesthetic surgery VAT audit classifies each procedure type, secures your CA3 declaration, and eliminates the risk of a back-tax audit covering up to 5 years.

CARMF and URSSAF contributions: planning ahead#

Estimated CARMF + URSSAF breakdown for a surgeon with €250,000 BNC (2026):

Automated accounting and tax filings#

We handle all your surgical accounting: automated bank statement imports, CCAM fee reconciliation (including surcharges, modifiers U/F/P), clinic levy deduction, surgical equipment tracking, 2035 declaration preparation and electronic submission.

Real-time dashboard: via our Pennylane platform, you permanently visualize your cash flow, fee receipts (CPAM + insurers + patients), deductible expenses, and estimated taxes and contributions.

Remuneration optimization#

Key deductible expenses to maximize:

• Professional liability insurance (RCP): €15,000 to €60,000/year — 100% deductible
• Operating theatre levies: 10-25% of surgical fees — deductible if properly qualified
• Medical equipment: depreciation of microscopes, arthroscopes, diagnostic tools over 5-10 years
• CPD training: surgical congresses, continuing medical education, journal subscriptions — 100% deductible

Madelin + PER combination: a surgeon with €300,000 BNC can deduct up to €104,000/year in pension/retirement contributions, saving up to €47,000/year in income tax.

Transition to SELARL or SELAS#

When should a surgeon incorporate?

Incorporation is strongly recommended from €150,000 to €200,000 in net profit. The differential between IS (15-25%) and IR (41-45%) becomes material at this level.

SELARL vs SELAS for surgeons:

Our missions: valuation of liberal fund, drafting SELARL articles of association, Ordre des Médecins procedures, registration, asset contribution, IS accounting setup.

SPFPL (medical holding): the optimal structure#

For a surgeon in SELARL generating €100,000 to €250,000 of annual IS profit, an SPFPL (Financial Participation Company for Liberal Professions) is the ultimate wealth structuring tool.

Concrete case — Dr. Laurent, orthopaedic surgeon, Paris 16th:

• SELARL generates €200,000 IS profit after tax
• Annual dividend distributed to SPFPL: €150,000
• Tax in SPFPL (parent-subsidiary regime): €150,000 × 5% × 25% = only €1,875
• SPFPL accumulates €148,125/year net to finance office premises purchase via SCI and rental property
• In 10 years: €1.5M capital built with less than €20,000 in total intermediate taxation

SCI and purchase of consultation office premises#

For surgeons with a consultation office, purchasing the premises via an SCI held by the SPFPL: rent paid by SELARL (IS-deductible), loan interest deductible from SCI results, build-up of transferable real estate assets.

Mistake 1: Remaining as sole proprietor too long#

Beyond €200,000 in net profit, the absence of incorporation represents an excess tax cost of €80,000 to €150,000/year. Hayot Expertise handles the entire process in 4 to 6 weeks.

Mistake 2: Misclassifying aesthetic procedures for VAT#

A plastic surgeon who does not charge VAT on purely aesthetic procedures risks a VAT audit covering 5 years of back taxes. Our aesthetic surgery VAT audit secures your declaration.

Mistake 3: Underestimating CARMF regularization#

The CARMF calls provisional contributions based on year N-2 income, then regularizes in N+1 on actual income. A surgeon whose activity has grown strongly may receive a regularization bill of €20,000 to €50,000 at once. Our quarterly monitoring anticipates this.

Mistake 4: Misclassifying clinic levies#

Confusing "operating block usage fees" (deductible BNC expense) with "share of clinic profits" (dividend distribution, non-deductible) can trigger double taxation. We secure the correct qualification of all clinic-related flows.

The professional liability insurance (RCP) premium carried by surgeons is one of the highest in the entire medical sector: from €15,000 to €60,000 per year depending on the specialty, with neurosurgery and cardiac surgery at the very top, and also on the geographic area and the practitioner's claims history. This charge is 100% deductible from your BNC (line 29 of the 2035 declaration).

Hayot Expertise optimization: we make sure the RCP premium is booked in the correct financial year, in line with the cash-basis principle that applies in BNC, that policy deductibles are treated properly, and that any retroactive contribution recalls are correctly allocated across the relevant years.

Most private surgeons operate within private clinics with which they hold a practice agreement (convention d'exercice). This agreement typically generates several distinct financial flows:

• Operating theatre levies, a deductible expense that often represents 10 to 20% of surgical fees
• SCM contributions, where the consultation office is shared with other practitioners
• Sometimes a share in the clinic's results

Our accounting treatment: we qualify each of these flows precisely, separating levies from rent and from operating charges, so as to maximize your deductibility and keep the correct treatment on file.

✅ Specialist in high-income healthcare professions: BNC 2035, CARMF, URSSAF, aesthetic surgery VAT, SELARL, SPFPL mastered ✅ Digital automation: Pennylane platform with bank import, invoice OCR, real-time dashboard ✅ 24-hour responsiveness: reply within 24 hours (often within 4 hours) ✅ Quantified tax optimization: detailed SELARL vs BNC simulations, PER + Madelin strategy, SPFPL ✅ Complete wealth support: SPFPL, SCI, office premises purchase, practice transmission

Cabinet Hayot Expertise — 58 rue de Monceau, 75008 Paris 📞 Request a free discovery meeting — Response within 24h

• Accountant for doctors
• Liberal professions accounting
• Wealth management for executives
• Business creation Paris
• Remuneration simulator
• Our pricing

Different surgical specialties produce very different financial profiles, and the right accounting structure depends on that profile.

Orthopaedic and trauma surgery typically generates the highest gross fees among Paris surgeons (€350-€500k per year for an established sector 2 surgeon), with significant clinic levies on operating-room usage (15-25% of fees). Implant supplier contracts, hardware kits and post-surgery follow-up structure the cash cycle. The SELARL + SPFPL combination is almost universal above €250k of net profit.

Plastic and aesthetic surgery carries the unique multi-VAT exposure described earlier: a single mixed practice (reconstructive + aesthetic) needs precise procedure-by-procedure classification. Aesthetic-only practices typically generate €400-€700k of fees, with VAT collected on most acts and a higher than average RC pro premium (€20-50k/year). Pre-treatment quotes, payment plans for cosmetic procedures and gift-voucher accounting all add complexity not seen in other specialties.

Visceral, digestive and neurosurgery combine high RC pro premiums (€30-€60k/year due to procedural risk) with often-lower volumes than orthopaedic surgery. The financial steering focuses on clinic-block coordination, hospital convention fees and the depreciation profile of any privately owned surgical equipment.

Cardiac, vascular and thoracic surgery typically operate in stricter hospital/clinic relationships, often with shared-block agreements that need careful accounting qualification. The high-pressure RCP premiums (often €40-€80k) require provisioning discipline.

A sector 1 surgeon (fully conventionné, no surcharges) benefits from a CPAM-financed portion of CARMF contributions (régime ASV) but is capped on official CCAM fees. A sector 2 surgeon (with surcharges) carries full CARMF cost but can adjust pricing within the limits of tact et mesure. The economic gap between the two sectors is significant (often €50-€150k of annual revenue), but the tax and contribution implications must be modelled together — a higher sector 2 income drives higher CARMF, URSSAF and IR brackets.

Retirement planning is a major topic. With marginal income tax rates at 45%, the Madelin retirement contract lets surgeons deduct up to €88,911/year in 2026 from their taxable BNC (10% of profit within 8 PASS plus 15% of the fraction between 1 and 8 PASS; the maximum is only reached from 8 PASS of profit, i.e. €384,480). The PER (Plan Épargne Retraite) can add deductible contributions where headroom remains under its general ceiling (10% of prior-year professional income within 8 PASS, at most €37,680 in 2026), but the two ceilings interact and do not simply add up. For a sector 2 surgeon generating €300k of net profit, the Madelin envelope alone reduces taxable BNC by around €67,800, saving roughly €30k/year in tax, a permanent annual lever.

When a private surgeon prepares retirement or sells their practice, two paths exist:

• Patient-base sale (cession de clientèle) to a younger colleague. Valuation typically ranges from 0.3× to 0.5× of annual fees for non-aesthetic specialties, higher for plastic/aesthetic. The sale generates a capital gain taxed under BNC plus-value rules, with full exemption available under article 151 septies CGI if revenues are below the threshold.
• SELARL share transfer (cession de parts de SELARL) when the surgeon operates through a company. Capital gain on shares is taxed at the 31.4% flat tax (2026 PFU: 12.8% income tax + 18.6% social levies). The Dutreil pact can apply to qualifying succession transfers, reducing donation rights by 75%.

We coordinate the valuation, structure the deal for optimal tax outcome, and prepare the financing file for the buyer.

1. Staying in BNC well past €250k of net profit#

The annual tax cost of staying as a sole trader instead of moving to a SELARL + SPFPL structure ranges from €50,000 to €150,000 above the €250k profit mark. We model the transition every year for surgeons approaching the threshold.

2. Misclassifying clinic levies#

"Operating-block usage fees" are a deductible BNC expense. "Share of clinic profits" is a dividend distribution and is not deductible. Confusing the two can trigger double taxation and a back-tax assessment. We secure the qualification of every clinic-related flow with the right contractual documentation.

3. Mixing aesthetic and reconstructive procedures for VAT#

A plastic surgeon who applies a single VAT treatment to all procedures risks a 5-year back-tax audit. Each procedure must be classified at the point of billing as therapeutic (VAT-exempt) or purely aesthetic (20% VAT), with the supporting medical justification archived in the patient file.

4. Letting the SPFPL accumulate cash without a reinvestment plan#

An SPFPL that simply holds cash year after year misses the tax-efficient compounding opportunity. We build a multi-year reinvestment plan covering office-premises SCI, life-insurance contracts within the holding, or partner buy-out funding.

5. Underestimating RC pro premium increases#

RC pro premiums in high-risk specialties (orthopaedic, neuro, cardiac) have risen 5-10% per year since 2022. Surgeons who do not re-tender their cover every 2-3 years often overpay by €5,000-€15,000/year. We coordinate the re-tender with our broker network.

These indicators are reviewed quarterly with the surgeon, ensuring that every lever — clinic levy negotiation, retirement saving, dividend distribution — is calibrated to the year's actual fee trajectory. The combination of monthly accounting discipline, annual structural review and proactive social-contribution provisioning is what turns a high-fee surgical practice into a high-net-cash, transmissible asset that supports both the surgeon's near-term lifestyle and their long-term family wealth strategy. For sector 2 surgeons in particular, the structural levers compound across an entire career — €30-€50k saved annually translates to €1-€1.5 million of additional capital over 25 years of practice.